These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 37089593)
1. Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry. Banner L; Joffe D; Lee E; Porcu P; Nikbakht N Front Med (Lausanne); 2023; 10():1110511. PubMed ID: 37089593 [TBL] [Abstract][Full Text] [Related]
2. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis. Eid E; Maloney NJ; Cai ZR; Zaba LC; Kibbi N; John EM; Linos E JAMA Dermatol; 2023 Nov; 159(11):1248-1252. PubMed ID: 37703005 [TBL] [Abstract][Full Text] [Related]
3. Primary Cutaneous B-Cell Lymphomas in Children and Adolescents: A SEER Population-Based Study. Bomze D; Sprecher E; Goldberg I; Samuelov L; Geller S Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e1000-e1005. PubMed ID: 34417159 [TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma and multiple primary cancers. Howard RA; Dores GM; Curtis RE; Anderson WF; Travis LB Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1545-9. PubMed ID: 16896047 [TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900 [TBL] [Abstract][Full Text] [Related]
6. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236 [TBL] [Abstract][Full Text] [Related]
7. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938 [TBL] [Abstract][Full Text] [Related]
8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions. Kempf W; Kazakov DV; Mitteldorf C Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377 [TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Sokol L; Naghashpour M; Glass LF Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899 [TBL] [Abstract][Full Text] [Related]
11. New Insights into Macular Type of Primary Cutaneous B-Cell Lymphoma: Extension of the Clinical and Histopathological Patterns. Barzilai A; Amitay-Laish I; Didkovsky E; Feinmesser M; Dalal A; Schiby G; Hodak E Dermatology; 2022; 238(6):1018-1025. PubMed ID: 35817021 [TBL] [Abstract][Full Text] [Related]
12. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Spanogle JP; Clarke CA; Aroner S; Swetter SM J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559 [TBL] [Abstract][Full Text] [Related]
13. Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia. Bzhalava D; Bray F; Storm H; Dillner J Br J Cancer; 2011 Jan; 104(1):178-80. PubMed ID: 21081931 [TBL] [Abstract][Full Text] [Related]
14. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas. Mao X; Orchard G Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027 [TBL] [Abstract][Full Text] [Related]
15. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US. Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623 [TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985 [TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma and melanoma: etiological similarities and differences. Miller RW; Rabkin CS Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):153-8. PubMed ID: 10067813 [TBL] [Abstract][Full Text] [Related]
18. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study. Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Joensuu H; Pukkala E Cancer Epidemiol; 2010 Feb; 34(1):62-5. PubMed ID: 20061203 [TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248 [TBL] [Abstract][Full Text] [Related]
20. Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016). Loya A; Gombos DS; Patel SP Front Oncol; 2022; 12():853076. PubMed ID: 35372013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]